370 related articles for article (PubMed ID: 27631260)
1. Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India.
Karade SK; Ghate MV; Chaturbhuj DN; Kadam DB; Shankar S; Gaikwad N; Gurav S; Joshi R; Sane SS; Kulkarni SS; Kurle SN; Paranjape RS; Rewari BB; Gangakhedkar RR
Medicine (Baltimore); 2016 Sep; 95(37):e4886. PubMed ID: 27631260
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study.
Karade SK; Kulkarni SS; Ghate MV; Patil AA; Londhe R; Salvi SP; Kadam DB; Joshi RK; Rewari BB; Gangakhedkar RR
PLoS One; 2017; 12(8):e0181889. PubMed ID: 28763465
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
4. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
[TBL] [Abstract][Full Text] [Related]
5. HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
Kityo C; Thompson J; Nankya I; Hoppe A; Ndashimye E; Warambwa C; Mambule I; van Oosterhout JJ; Wools-Kaloustian K; Bertagnolio S; Easterbrook PJ; Mugyenyi P; Walker AS; Paton NI;
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):e45-e54. PubMed ID: 28129253
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.
Rhee SY; Jordan MR; Raizes E; Chua A; Parkin N; Kantor R; Van Zyl GU; Mukui I; Hosseinipour MC; Frenkel LM; Ndembi N; Hamers RL; Rinke de Wit TF; Wallis CL; Gupta RK; Fokam J; Zeh C; Schapiro JM; Carmona S; Katzenstein D; Tang M; Aghokeng AF; De Oliveira T; Wensing AM; Gallant JE; Wainberg MA; Richman DD; Fitzgibbon JE; Schito M; Bertagnolio S; Yang C; Shafer RW
PLoS One; 2015; 10(12):e0145772. PubMed ID: 26717411
[TBL] [Abstract][Full Text] [Related]
7. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.
Jiamsakul A; Sungkanuparph S; Law M; Kantor R; Praparattanapan J; Li PC; Phanuphak P; Merati T; Ratanasuwan W; Lee CK; Ditangco R; Mustafa M; Singtoroj T; Kiertiburanakul S;
J Int AIDS Soc; 2014; 17(1):19053. PubMed ID: 25141905
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients.
Barth RE; Aitken SC; Tempelman H; Geelen SP; van Bussel EM; Hoepelman AI; Schuurman R; Wensing AM
Antivir Ther; 2012; 17(2):377-86. PubMed ID: 22297391
[TBL] [Abstract][Full Text] [Related]
9. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.
Hosseinipour MC; van Oosterhout JJ; Weigel R; Phiri S; Kamwendo D; Parkin N; Fiscus SA; Nelson JA; Eron JJ; Kumwenda J
AIDS; 2009 Jun; 23(9):1127-34. PubMed ID: 19417582
[TBL] [Abstract][Full Text] [Related]
10. Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.
Rhee SY; Varghese V; Holmes SP; Van Zyl GU; Steegen K; Boyd MA; Cooper DA; Nsanzimana S; Saravanan S; Charpentier C; de Oliveira T; Etiebet MA; Garcia F; Goedhals D; Gomes P; Günthard HF; Hamers RL; Hoffmann CJ; Hunt G; Jiamsakul A; Kaleebu P; Kanki P; Kantor R; Kerschberger B; Marconi VC; D'amour Ndahimana J; Ndembi N; Ngo-Giang-Huong N; Rokx C; Santoro MM; Schapiro JM; Schmidt D; Seu L; Sigaloff KCE; Sirivichayakul S; Skhosana L; Sunpath H; Tang M; Yang C; Carmona S; Gupta RK; Shafer RW
EBioMedicine; 2017 Apr; 18():225-235. PubMed ID: 28365230
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.
De Luca A; Sidumo ZJ; Zanelli G; Magid NA; Luhanga R; Brambilla D; Liotta G; Mancinelli S; Marazzi MC; Palombi L; Ceffa S
BMC Infect Dis; 2017 Sep; 17(1):605. PubMed ID: 28870148
[TBL] [Abstract][Full Text] [Related]
12. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa.
Sigaloff KC; Hamers RL; Wallis CL; Kityo C; Siwale M; Ive P; Botes ME; Mandaliya K; Wellington M; Osibogun A; Stevens WS; van Vugt M; de Wit TF;
J Acquir Immune Defic Syndr; 2011 Sep; 58(1):23-31. PubMed ID: 21694603
[TBL] [Abstract][Full Text] [Related]
13. Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia.
Hudson FP; Mulenga L; Westfall AO; Warrier R; Mweemba A; Saag MS; Stringer JS; Eron JJ; Chi BH
Antivir Ther; 2019; 24(4):291-300. PubMed ID: 30977467
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
van Zyl GU; van der Merwe L; Claassen M; Zeier M; Preiser W
J Med Virol; 2011 Oct; 83(10):1764-9. PubMed ID: 21837793
[TBL] [Abstract][Full Text] [Related]
16. HIV drug resistance following a decade of the free antiretroviral therapy programme in India: A review.
Karade S; Chaturbhuj DN; Sen S; Joshi RK; Kulkarni SS; Shankar S; Gangakhedkar RR
Int J Infect Dis; 2018 Jan; 66():33-41. PubMed ID: 29128646
[TBL] [Abstract][Full Text] [Related]
17. Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.
Hoffmann CJ; Ledwaba J; Li JF; Johnston V; Hunt G; Fielding KL; Chaisson RE; Churchyard GJ; Grant AD; Johnson JA; Charalambous S; Morris L
Antivir Ther; 2013; 18(7):915-20. PubMed ID: 23751421
[TBL] [Abstract][Full Text] [Related]
18. Virologic status and pattern of drug resistance mutation among ART-experienced HIV-infected patients in Butuo County, China.
Chen M; Wu M; Zeng L; Zhang Y; Huobu-Mo M; Li J; Li C; Xiao H
J Glob Antimicrob Resist; 2023 Mar; 32():98-103. PubMed ID: 36708768
[TBL] [Abstract][Full Text] [Related]
19. From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.
Namakoola I; Kasamba I; Mayanja BN; Kazooba P; Lutaakome J; Lyagoba F; Kapaata AA; Kaleebu P; Munderi P;
BMC Res Notes; 2016 Dec; 9(1):515. PubMed ID: 28010730
[TBL] [Abstract][Full Text] [Related]
20. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
